| Literature DB >> 35415635 |
Saleha Akter1, Rama Addepalli2, Michael Netzel1, Mary Fletcher1, Yasmina Sultanbawa1, Simone Osborne2.
Abstract
Terminalia ferdinandiana (Kakadu plum) is a native Australian fruit consumed by Indigenous Australians for centuries. Commercial interest in T. ferdinandiana has increased in recent years due to its high vitamin C content, however, food safety assessments are lacking. To explore the safety of extracts prepared from T. ferdinandiana using different solvents, in vitro cell viability of undifferentiated and differentiated Caco-2, HT29-MTX-E12, and HepG2 cells was measured using the CyQUANT® NF Cell Proliferation Assay. Changes to cell viability produced IC50 values between 3650 and 14400 µg/mL for all extracts and cell lines tested with HepG2 cells impacted the most by T. ferdinandiana extracts, followed by HT29-MTX-E12 cells, and undifferentiated and differentiated Caco-2 cells. Different solvents also produced extracts with variable effects on cell viability that were dependent on tissue source, however, extracts from seedcoats appeared to impact cell viability less than fruit extracts. The IC50 values for ellagic acid, an abundant phytochemical in T. ferdinandiana, varied from 1190 to 2390 µg/mL across different cells and were significantly lower than extract IC50 values. Findings from this study will help to inform future safety studies, select which solvents to use when preparing T. ferdinandiana extracts, and decide whether fruit flesh should be separated from seeds during extract preparation.Entities:
Keywords: Cell viability; CyQUANT® NF Cell Proliferation Assay; Ellagic acid; HepG2; Kakadu plum; Terminalia ferdinandiana
Year: 2021 PMID: 35415635 PMCID: PMC8991618 DOI: 10.1016/j.fochms.2021.100024
Source DB: PubMed Journal: Food Chem (Oxf) ISSN: 2666-5662
Fig. 1Treatment concentration–response curve for fruit methanol (FM), seedcoat methanol (SM), fruit water (FW), seedcoat water (SW), fruit ethanol (FE) and seedcoat ethanol (SE) extract expressed as percentage viable intestinal and liver cells remaining after 2 h treatment compared to the HBSS control in (A) Undifferentiated Caco-2; (B) Differentiated Caco-2; (C) HT29-MTX-E12; and (D) HepG2 in CyQUANT® NF Cell Proliferation Assay. The data is presented as the mean percentage (±SEM) of six replicates for each treatment.
IC 50 values obtained using the CyQUANT® NF Cell Proliferation Assay.
| FM (µg/mL) | SM (µg/mL) | FW (µg/mL) | SW (µg/mL) | FE (µg/mL) | SE (µg/mL) | Standard ellagic Acid (µg/mL) | |
|---|---|---|---|---|---|---|---|
| Undifferentiated Caco-2 | 4550 ± 600 I, a | 11700 ± 360 I, x | 7350 ± 320 I, b, | 7040 ± 750 I, y | 6220 ± 330 I, c | 14400 ± 460 I, z | 1190 ± 180 |
| Differentiated Caco-2 | 5540 ± 470 II, a | 4120 ± 530 II, x | 5390 ± 600 II, IV, a | 3740 ± 400 II, V, x | 6420 ± 900 I, a | 10900 ± 100 II, y | 1210 ± 140 |
| HT29-MTX-E12 | 7170 ± 490 III, a | 8290 ± 240 III, x | 7110 ± 270 I, a | 3650 ± 280 III, V, y | 4820 ± 74 II, V, b | 7360 ± 600 III, V, z | 2390 ± 480 |
| HepG2 | 4300 ± 480 I, a | 7740 ± 190 III, x | 6000 ± 900 III, IV, b, c | 4700 ± 310 IV, y | 5000 ± 280 III, IV, a, c | 6700 ± 860 IV, V, z | 2000 ± 630 |
Results are expressed as mean ± SD; (n = 6); mean values of each column with different numerals and letters are significantly different (P ≤ 0.05); a, b, c, denotes significant differences of extraction solvents within fruits and ×, y, z denotes significant differences of extraction solvents in seedcoats within the same cell type; I – V denotes significant differences of the same extract across different cell types.
Unpaired t test values for the difference of means between the IC50 of fruit extracts and seedcoat extracts of T. ferdinandiana in various cell lines using CyQUANT® NF Cell Proliferation Assay.
| Fruits | Seedcoats | Mean Difference Fruits/Seedcoats | 95% CI | R squared | ||
|---|---|---|---|---|---|---|
| Undifferentiated Caco-2 | ||||||
| Methanol | 4550 ± 600 | 11700 ± 360 | 7150 | 6430 to 7880 | <0.0001 | 0.99 |
| Water | 7350 ± 320 | 7040 ± 750 | −300 | −1150 to 540 | 0.44 | 0.08 |
| Ethanol | 6220 ± 330 | 14400 ± 460 | 8220 | 7640 to 8800 | <0.0001 | 0.99 |
| Differentiated Caco-2 | ||||||
| Methanol | 5540 ± 470 | 4120 ± 530 | −1420 | −2150 to −680 | 0.002 | 0.71 |
| Water | 5390 ± 600 | 3740 ± 400 | −1650 | −2400 to −890 | 0.001 | 0.76 |
| Ethanol | 6420 ± 900 | 10900 ± 100 | 4500 | 3550 to 5450 | <0.0001 | 0.94 |
| HT29-MTX-E12 | ||||||
| Methanol | 7170 ± 490 | 8290 ± 240 | 1120 | 550 to 1700 | 0.0018 | 0.72 |
| Water | 7110 ± 270 | 3650 ± 280 | −3450 | −3860 to −3050 | <0.0001 | 0.98 |
| Ethanol | 4820 ± 74 | 7360 ± 600 | 4500 | 1900 to 3170 | <0.0001 | 0.92 |
| HepG2 | ||||||
| Methanol | 4300 ± 480 | 7740 ± 190 | 3440 | 2900 to 3970 | <0.0001 | 0.97 |
| Water | 6000 ± 900 | 4700 ± 310 | −1300 | −2290 to −310 | 0.016 | 0.54 |
| Ethanol | 5000 ± 280 | 6700 ± 860 | 1700 | 760 to 2630 | 0.0031 | 0.69 |
Fig. 2Treatment concentration–response curves for ellagic acid using CyQUANT® NF Cell Proliferation Assay expressed as percentage viable intestinal and liver cells remaining after 2 h treatment compared to the HBSS control in (A) Undifferentiated Caco-2, (B) Differentiated Caco-2, (C) HT29-MTX-E12 and (D) HepG2. The data is presented as the mean percentage (±SEM) of six replicates for each treatment.